Icon

EVISTA (nda020815)- (60MG)

RALOXIFENE HYDROCHLORIDE LILLY
60MG
Yes No
2017-Apr-14 Expired
2014-Sep-13 None
None No
EVISTA® is an estrogen agonist/antagonist indicated for: • Treatment and prevention of osteoporosis in postmenopausal women. • Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. • Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.
8 0 7
Total Other Developers 3
Drugs with Suitability No
60MG ** ** - - 6
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ***************, *** *********** * **** ***., *********, *** **** (**) *****, ****** ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ******* ****** *** ******* ***************, ***. *********** ** ***** *****, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ***** ******** *.*.*. *********** ****** ****** ********** **, ******, *****, ******* (***) ***
****** ****** ****** *** ****** *************** ******* *********** ****, ****** ****, ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.